Anti-Golgi autoantibodies are not clinically associated with systemic autoimmune diseases.

摘要

Anti-Golgi antibodies were first described in 1982 in a patient with Sjogren's syndrome (SjS) with a lymphoma. They have mainly been reported in patients with SjS and systemic lupus erythematosus (SLE), but also in patients with other systemic autoimmune diseases such as rheumatoid arthritis and non-autoimmune disorders such as idiopathic cerebellar ataxia and HIV infection. Transient low titres have also been reported in patients with a probable viral infection.